These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 12621983)

  • 1. [Anticoagulant treatment of patients with atrial fibrillations: dependent on age and other risk factors for thromboembolism].
    Hoefnagels WA; van Reisen AG
    Ned Tijdschr Geneeskd; 2003 Feb; 147(6):267-8; author reply 268-9. PubMed ID: 12621983
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anticoagulant treatment of patients with atrial fibrillations: dependent on age and other risk factors for thromboembolism].
    Vink R; van den Brink RB; Levi M
    Ned Tijdschr Geneeskd; 2002 Nov; 146(48):2285-9. PubMed ID: 12497755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation.
    Hylek EM
    Thromb Haemost; 2008 Jul; 100(1):16-7. PubMed ID: 18612532
    [No Abstract]   [Full Text] [Related]  

  • 4. Left atrial thrombus, transient ischemic attack, and atrial fibrillation: does left atrial thrombus predict? Does absence protect?
    Sheahan RG
    Am Heart J; 2003 Apr; 145(4):582-5. PubMed ID: 12679752
    [No Abstract]   [Full Text] [Related]  

  • 5. Thromboembolic events occur despite sinus rhythm maintenance in patients treated for atrial fibrillation: The Canadian Trial of Atrial Fibrillation experience.
    Thibault B; Talajic M; Dubuc M; Guerra P; Gagné P; Roy D; Connolly S;
    Can J Cardiol; 2004 Feb; 20(2):195-9. PubMed ID: 15010743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting thromboembolism and selecting patients for anticoagulant therapy in atrial fibrillation.
    Weintraub WS
    J Am Coll Cardiol; 2008 Feb; 51(8):816-7. PubMed ID: 18294565
    [No Abstract]   [Full Text] [Related]  

  • 7. Sustainability and impact of warfarin compliance for atrial fibrillation.
    Kuo S; Burrill J
    Med Health R I; 2007 Dec; 90(12):378-80. PubMed ID: 18314828
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevention of thromboembolic complications in patients with atrial fibrillation.
    Spiezia L; Prandoni P
    Minerva Cardioangiol; 2008 Dec; 56(6):643-52. PubMed ID: 19092739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pro: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Why warfarin should really be the drug of choice for stroke prevention in elderly patients with atrial fibrillation.
    Mant JW
    Thromb Haemost; 2008 Jul; 100(1):14-5. PubMed ID: 18612531
    [No Abstract]   [Full Text] [Related]  

  • 10. [Atrial fibrillation and anticoagulant therapy].
    Mokaddem A; Khouadja MA; Dargouth B; Sdiri W; Joulak A; Saidi I; Selmi K; Makni H; Boujnah MR
    Tunis Med; 2005 Feb; 83 Suppl 2():1-5. PubMed ID: 15991613
    [No Abstract]   [Full Text] [Related]  

  • 11. Atrial fibrillation and atherothrombosis: the importance of anticoagulation.
    Escobar C; Barrios V
    Am Heart J; 2009 May; 157(5):e27; author reply e29. PubMed ID: 19376295
    [No Abstract]   [Full Text] [Related]  

  • 12. Epidemiology, risk factors for stroke, and management of atrial fibrillation in China.
    Hu D; Sun Y
    J Am Coll Cardiol; 2008 Sep; 52(10):865-8. PubMed ID: 18755352
    [No Abstract]   [Full Text] [Related]  

  • 13. D-dimer level influences thromboembolic events in patients with atrial fibrillation.
    Nozawa T; Inoue H; Hirai T; Iwasa A; Okumura K; Lee JD; Shimizu A; Hayano M; Yano K
    Int J Cardiol; 2006 Apr; 109(1):59-65. PubMed ID: 15992948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial fibrillation--rate versus rhythm control.
    Manning WJ
    N Engl J Med; 2003 Mar; 348(13):1284-6; author reply 1284-6. PubMed ID: 12661569
    [No Abstract]   [Full Text] [Related]  

  • 15. Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis.
    Ruiz-Nodar JM; Marín F; Hurtado JA; Valencia J; Pinar E; Pineda J; Gimeno JR; Sogorb F; Valdés M; Lip GY
    J Am Coll Cardiol; 2008 Feb; 51(8):818-25. PubMed ID: 18294566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of bleeding in patients with nonvalvular atrial fibrillation treated with ximelagatran or warfarin: assessment of incidence, case-fatality rate, time course and sites of bleeding, and risk factors for bleeding.
    Douketis JD; Arneklev K; Goldhaber SZ; Spandorfer J; Halperin F; Horrow J
    Arch Intern Med; 2006 Apr; 166(8):853-9. PubMed ID: 16636210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrial fibrillation and anticoagulation.
    Garnier LF; Rouesnel P; Espitalier F
    Arch Mal Coeur Vaiss; 2004 Oct; 97(10):1001-5. PubMed ID: 16008178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrin D-dimer levels and thromboembolic events in patients with atrial fibrillation.
    Watson T; Shantsila E; Lip GY
    Int J Cardiol; 2007 Aug; 120(1):123-4; author reply 125-6. PubMed ID: 17055595
    [No Abstract]   [Full Text] [Related]  

  • 19. Letter 2: Prevention of perioperative thromboembolism in patients with atrial fibrillation (Br J Surg 2007; 94: 1351-1355).
    Potter J
    Br J Surg; 2008 Mar; 95(3):399-400; author reply 400. PubMed ID: 18278793
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?].
    Selçuk H; Selçuk MT; Maden O
    Anadolu Kardiyol Derg; 2007 Mar; 7(1):54-8. PubMed ID: 17347079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.